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The impact of two different quality feeds, derived using two different harvest clariﬁcation pro-
cesses, on protein A periodic counter-current chromatography (PCC) design and performance
is investigated. Data from batch experiments were input into a model to design optimal PCC
operating parameters speciﬁc to each feed material. The two clariﬁcation methods were: depth
ﬁltration using a wetlaid matrix which has Q-functionality; and a combination of depth ﬁltration
and chromatographic clariﬁcation, using a Q-functional nonwoven with a high anion exchange
capacity (Emphaze™ AEX Hybrid Puriﬁer) in which key impurities such as host cell DNA
(HCDNA) and host cell proteins (HCP) are removed. The model predicted 34% better produc-
tivity for the chromatographically clariﬁed cell culture ﬂuid (CCCF) using a 4 column system,
and productivity gains of 28% using only 3 columns enabling the option to simplify the protein
A PCC strategy. Experimental validation of the predicted optimized PCC operating parameters
using industrially relevant monoclonal antibody (mAb) CCCF feedstock over 100 cycles showed
productivity gains of 49% for the chromatographically clariﬁed material. HCP concentration
was 11-fold lower, and HCDNA concentration was reduced by 4.4 Log Reduction Value (LRV)
in the protein A PCC eluates. This work, therefore, demonstrates that the removal of HCDNA
and HCP during clariﬁcation is an effective strategy for improving protein A PCC performance.
This was achieved using the Emphaze™ AEX Hybrid Puriﬁer which can be easily incorporated
into a batch or continuous process, in a scalable fashion, without adding additional separate
unit operations. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 2018
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Introduction
Continuous processing has the potential to bring many
advantages to the production of biotherapeutics such as lower
capital costs, due to the use of smaller equipment and storage
vessels, higher productivity, lower buffer consumption, and the
possibility of steady-state operation in some circumstances.1–3
A number of academic and commercial entities are currently
exploring continuous processing for recombinant protein
manufacturing.4 However, adoption has been slow due to the lack
of a regulatory precedent, the need for better online process ana-
lytics (PAT) to improve process control, the inertia due to exist-
ing capital equipment for batch processing, and the perceived
complexity associated with continuous manufacturing.3,5–8
A signiﬁcant amount of work has been done by different
research groups on periodic counter-current chromatography
(PCC), and several groups have demonstrated capacity utiliza-
tion and productivity gains over batch systems in most cases.9–12
There has also been some work, using decisional tools, which
demonstrates the economic beneﬁts of inclusion of continuous
capture chromatography as part of a hybrid approach for
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commercial production.13 However, as with continuous proces-
sing in general, one of the barriers to implementation of continu-
ous multicolumn chromatography is system complexity,
particularly, when more than 4 columns are used.14
Higher titer feed materials generally tend to increase system
complexity. This is because, as the load time becomes shorter,
there is a requirement for more columns to maintain the bal-
ance between loading and regeneration which is the key to
maximizing productivity.15 The alternative is to reduce the
regeneration time by pre-treating the feed material to remove
host cell protein (HCP) and host cell DNA (HCDNA). This
may enable further optimization of the regeneration steps and
allow fewer columns to be used, reducing system complexity.3
In this work this hypothesis is tested.
Different modeling and design approaches have been pro-
posed by various research groups.9,10,16–18 The majority of these
are complex and therefore not simple to implement. The model
proposed by Gjoka et al. is much less complex, but requires a
nonstandard column setup, that is, two columns in series with
two UV detectors. Also, while productivity and capture efﬁ-
ciency predictions were made, only the capture efﬁciency
appears to have been validated experimentally. In this work, a
simple methodology using standard batch chromatography
equipment for the design and optimization of a protein A PCC
capture step for maximum productivity is presented. Experimen-
tal validation of the results using industry relevant CHO
expressed monoclonal antibody (mAb) CCCF is provided.
Chromatographic clariﬁcation, using Q-functional nonwo-
ven technology, has been shown to result in levels of HCDNA
3.5 logs lower and HCP 19 times lower in the protein A col-
umn eluate, compared to material clariﬁed by depth ﬁlter
alone.19 The Emphaze™ AEX Hybrid Puriﬁer enables reduc-
tion of soluble and insoluble contaminants by charge using a
Q-functional nonwoven matrix. It consists of four layers of
quaternary ammonium functionalized nonwoven followed by
an asymmetric polyamide membrane with a ﬁnal pore size of
0.2 μm. Due to the open media structure and high anion
exchange capacity, it is able to handle signiﬁcant turbidity
while removing soluble impurities. This work aims to investi-
gate whether similar improvements in post protein A purity
can also be seen post protein A PCC.
Protein A performance was compared using single column,
single cycle, batch runs on control (depth ﬁltered) and chro-
matographically clariﬁed CCCF. The batch data were then
used to design a PCC unit operation optimized for each feed
material using a simple model. The design was evaluated
experimentally by conducting 100 cycles of PCC. The experi-
mentally obtained performance with each feed material was
then compared to investigate the impact of feed quality on the
performance of the PCC unit operation in terms of productiv-
ity, capacity utilization, and purity.
Theoretical Considerations
PCC theory
The steps required for a batch chromatography unit opera-
tion include equilibration of the chromatography column,
loading, post-load wash, elution, column cleaning, and re-
equilibration. The same steps are required in a PCC unit oper-
ation, but they are divided into two groups—loading and
regeneration (which includes the post-load wash, elution,
cleaning, and re-equilibration).
In addition to these steps, the PCC unit operation will have
two or more columns in the loading zone. This enables the
capacity of the ﬁrst chromatography column to be more fully
utilized by capturing product which ﬂows through when it is
overloaded. It is this greater utilization of capacity that leads
to lower buffer consumption and smaller column size.17
The three key steps in a PCC unit operation are feed, ﬂow-
through loading, and regeneration. Tables 1–3 show the order
of these steps in a single cycle on a 2, 3, and 4 column PCC
system. The ﬂowthrough loading is referred to simply as ﬂow-
through in these tables. From the tables, it can be seen that
each column is subject to each of the steps described above,
but with different steps happening in parallel on different col-
umns. It is this parallel operation that contributes to the pro-
ductivity gains compared to batch processing.
Changing the number of columns changes the relative
length of the feed and regeneration steps with feed being lon-
ger than regeneration for a 2 column system, feed being the
same as regeneration for a 3 column system, and feed being
shorter than the regeneration for a 4 column system.
Model
A model to predict the productivity of a PCC chromatography
unit operation was developed for 2, 3, and 4 column systems
building on previously published work9,20. The maximum num-
ber of columns was limited to four to minimize system complex-
ity. However, the model is adaptable for more columns.
The underlying assumptions of the model are as follows:
• All mass that is not bound by the feed column (Mub) is
bound by the ﬂowthrough column.
• This model ignores any kinetic effects due to the different
concentration that is loaded onto a fresh column in the ﬁrst
load step of the ﬁrst cycle (C0) and the variable concentra-
tion that is loaded onto the ﬂowthrough column during all
other cycles (CFT).
• Breakthrough curve shape is identical between the ﬁrst
cycle and the nth cycle.
• All bound product is recovered from the model during the
elution.
The productivity (P) is deﬁned as the total mass, in grams,
bound (MT) per unit volume of chromatography resin, in liters,




Figure 1 shows theoretical breakthrough curves for a single
cycle of a 4 column PCC run. The load on the ﬁrst column,
Table 1. Table Showing the Steps in a PCC Cycle for a System
Containing Two Columns





Table 2. Table Showing the Steps in a PCC Cycle for a System
Containing Three Columns
Step Column 1 Column 2 Column 3
1 Feed Flowthrough Regeneration
2 Regeneration Feed Flowthrough
3 Flowthrough Regeneration Feed
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during the ﬁrst cycle, is the longest as it has not been pre-
loaded with any product. For the second, third and fourth col-
umn, and subsequent cycles, the length of the load is reduced
by tp which is the length of time required to load a quantity of
feed material containing the same amount of product as that
which ﬂows through the preceding column, that is, Mub. This
is because each of these columns will already have been
exposed to a preload equal to Mub.
As it is assumed that all product either binds to the feed or ﬂow-
through column, the sum of the area above and below each of
these curves will give rise to the total quantity of product bound.
This gives rise to Eq. 2, whereMb is the quantity of bound protein,
Nc is the number of columns, and X is the number of cycles
MT ¼XNcMb +Mub ð2Þ
The unbound mass is evaluated from the area under a single
column breakthrough curve up to the desired level of product
breakthrough. This is expressed in Eq. 3, where Q is the volu-
metric ﬂowrate of the feed, CFT(t) is the concentration of product
in the column ﬂowthrough as a function of time, and t is the time
at which the desired percentage breakthrough is achieved. When
selecting the desired percentage breakthrough, for PCC conﬁgu-
rations where there are two columns in the loading zone, the
unbound mass should not be larger than the amount of product
that would be loaded under batch operations (tDBC) as this would
lead to product loss. For the purpose of this work, this value was
less than or equal to the mass of antibody contained in 80% of




CFT tð Þdt ð3Þ
The bound mass is evaluated from the area above a single
column breakthrough curve as expressed in Eq. 4, where C0 is
the feed concentration
Mb ¼C0tQ−Mub ð4Þ
The total run time tT is expressed by Eq. 5, where ti is the
time required for equilibrating the ﬁrst column in preparation
to be loaded, ts is the length of time at which the feed is
switched to the next column, and tRF is the regeneration time
of any loaded columns after all cycles have been completed
tT ¼ ti + tp +XNctS + tRF ð5Þ
The primary difference between the 2, 3, and 4 column
models is in the regeneration time. To maximize throughput,
the feed should be loading onto a column throughout the
cycle. For a 2 column system, where the feed is loading onto
a single column while regeneration is taking place, the regen-
eration time tR should be shorter than the time taken for the
antibody to begin breaking through the ﬁrst column (tDBC) or
antibody will be lost. These criteria are expressed in Eqs. 6–8,
where tL is the load time and tBT-DBC is the time between tDBC
and the desired percentage breakthrough
tR ≤ tDBC ð6Þ
tL ¼ tS ¼ tDBC + tBT−DBC ð7Þ
tL ¼ t− tp ð8Þ
For 3 column systems, the regeneration time should simply
be shorter than the loading time tL, as expressed in Eqs. 9 and
10, otherwise the column will not be loading all the time
which will reduce productivity
tS ¼ tLwhen tL ≥ tR ð9Þ
tS ¼ tRwhen tL < tR ð10Þ
For the 4 column system, the regeneration step is split into
two sections and occurs over two load steps. The total regen-
eration must again be complete within those two load steps
otherwise there will be an interruption to loading which will
reduce productivity as expressed in Eqs. 11 and 12
tS ¼ tLwhen tL ≥ tR2 ð11Þ




Figure 2 shows the process that was used to arrive at the
operating conditions for the two feed materials used in this
Table 3. Table Showing the Steps in a PCC Cycle for a System Containing Four Columns
Step Column 1 Column 2 Column 3 Column 4
1 Feed Flowthrough Regeneration 2 Regeneration 1
2 Regeneration 1 Feed Flowthrough Regeneration 2
3 Regeneration 2 Regeneration 1 Feed Flowthrough
4 Flowthrough Regeneration 2 Regeneration 1 Feed
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Figure 1. Diagram of theoretical breakthrough curves for a PCC run with four columns. Mb is the mass of protein bound to column.
Mub is the quantity of protein that ﬂows through the ﬁrst column in the loading zone and binds to the second column and tp is
the preload time, which is the time required to load a quantity of product equivalent to Mub.
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work. The PCC operating conditions for each feed material
where arrived at independently of the other. All steps with the
exception of Step 5 were undertaken in this study. While fur-
ther optimization of residence time for the Emphaze™ AEX
Hybrid Puriﬁer feed material could have been achieved by
generation of breakthrough curves at intermediate residence
times, the conditions for the 90ZB08A feed material were near
optimal. Further optimization of the Emphaze™ AEX Hybrid
Puriﬁer feed material was judged not to be necessary as a dif-
ference in productivity had already been demonstrated.
Materials and Methods
Reagents
Citric acid, sodium phosphate monobasic monohydrate, and
sodium phosphate dibasic heptahydrate were purchased from
Fisher Chemicals (Loughborough, U.K.). Glacial acetic acid was
purchased from VWR (Lutterworth, U.K.). Sodium hydroxide
pellets, sodium chloride, Tris-hydrochloride, Tris-base, sodium
sulphate, sulphuric acid, hydrochloric acid, and glycine were
purchased from Sigma-Aldrich (Gillingham, U.K.).
Common buffers
The following buffers were used routinely through this arti-
cle and are deﬁned here:
• Equilibration buffer: 20 mM sodium phosphate,150 mM
NaCl, pH 7.0.
• Elution buffer: 100 mM citrate buffer, pH 3.2.
• Neutralization buffer: 1 M Tris–HCl buffer, pH 9.0.
All buffers were ﬁltered through a LifeASSURE™
PDA020 0.2 μm sterilizing grade membrane ﬁlters (3M, St
Paul, MN, USA) prior to use.
Preparation of feed for chromatography runs
A tocilizumab biosimilar feed stock was produced in CHO
cell culture. The material was produced in fed-batch in two
50 L disposable stirred tank bioreactors (Eppendorf, Hamburg,
Germany) up to cell densities of 5.7 × 106 cells/mL and
6.6 × 106 cells/mL, with ﬁnal viabilities of 64% and 74%,
respectively. The bioreactors were harvested on day 14 sepa-
rately through a 30SP02A primary Zeta Plus™ depth ﬁlter
(3M) at throughputs of 75 L/m2 and 78 L/m2, respectively,
and a ﬂux of 261 liters per meter square per hour (LMH).
The 30SP02A ﬁltrates were then pooled and mixed. The anti-
body titer of this material was measured as described in the Ana-
lytics section of the Materials and Methods and was 3.5 g/L. A
portion of the pool was further clariﬁed through a 90ZB08A
Zeta Plus™ polishing grade depth ﬁlter (3M) which contains
Q functionality and is highly charged compared to other depth
ﬁlters. A throughput of 243 L/m2 and ﬂux of 197 LMH was
achieved. It was then sterile ﬁltered using a 0.2 μm Life-
ASSURE™ PDA membrane ﬁlter (3M) at a throughput of
207 L/m2 and ﬂux of 168 LMH. This material was aliquoted
and frozen at −80C. It is referred to in this article as “depth
Step 4
Optimise regeneration time by
reducing length of steps where
possible and or reducing
residence time for regeneration
steps and generate experimental
data to determine ti, tR and tRF.
Step 2 
Evaluate productivity at different
residence times, for systems with
different numbers of columns.  
Step 3 
Select conditions that achieve
maximum productivity
Step 5
Optimise loading by 
choosing new residence 
times to test.
Step 1 
Generate breakthrough curves on a single
column to determine Mub, Mb, tDBC, tp and tL
experimentally at different residence times and
breakthrough levels.
Set and test initial regeneration conditions
during generation of breakthrough curves to
determine ti, tR and tRF.
Are the loading and 
regeneration times 
equal see equations 
6-12
No regeneration 
time is too long
Yes




Figure 2. Process for using the PCC model to optimize for maximum productivity.
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ﬁlter clariﬁed material,” and represents material clariﬁed through
a highly charged depth ﬁlter train.
A separate portion of the 30SP02A ﬁltrate material was fur-
ther clariﬁed using the Emphaze™ AEX Hybrid Puriﬁer, a
ﬂowthrough anion exchange chromatography product (FT-
AEX) able to handle turbidity (3M), at a throughput of 262 L/
m2 and a ﬂux of 197 LMH, and then through a 0.2 μm Life-
ASSURE™ PDA membrane ﬁlter (3M) at a throughput of
223 L/m2 and ﬂux of 168 LMH. This material was also ali-
quoted and frozen at −80C and is referred to in this article as
“FT-AEX clariﬁed material.”
Feed material was thawed at room temperature prior to use.
As no changes to turbidity or particulates were observed in
either of the thawed feeds, ﬁltration with a 0.2 μm membrane
was not conducted prior to use. All measurements reported
were conducted on the thawed material.
Single column breakthrough curves
An ÄKTA™ Avant chromatography system (GE, Uppsala,
Sweden) was used for all single column experiments. HiTrap
MabSelect SuRe™ 1 mL columns (GE), with a bed height of
2.5 cm, were use. Separate columns were used for depth ﬁlter
and FT-AEX clariﬁed feed materials. All samples were
applied to the columns using the sample pump.
Breakthrough Curves. Breakthrough curves were developed
by overloading the column with sample and analyzing the
ﬂowthrough samples for antibody concentration. The method
steps, buffers, ﬂow rates, and volumes are listed in Table 4.
Fractions were collected every 0.5 mL from the start of feed
loading, in a 96 well deepwell plate, until the end of sample
application. The elution fraction peak was automatically col-
lected in a 15 mL falcon tube when the UV 280 nm signal rose
above 50 mAU. The tube was prepared with 0.42 mL neutrali-
zation buffer. The whole acid strip fraction was collected in a
15 mL falcon tube containing 1.2 mL neutralization buffer. All
fractions were analyzed on a Protein G column as described in
the Analytics section of the Materials and Methods.
Batch Run. A low load volume batch run was performed by
modifying the method described in the Breakthrough Curves
section. The feed step was performed with the depth ﬁlter clar-
iﬁed feed material at a ﬂow rate of 0.25 mL/min and a load
volume of 9 mL. All other ﬂow rates were modiﬁed to
0.5 mL/min with the exception of the sanitisation step which
was kept at 0.3 mL/min. All other step volumes were kept
constant. Fractionation was also modiﬁed with the feed step
collected as a whole fraction and 0.84 mL of Tris neutraliza-
tion buffer added to the elution fraction.
Long Load Batch Run. Speciﬁc single column batch experi-
ments were run with conditions similar to those in the PCC
operation. An extended feed step was performed based on the
total load volume predicted by the PCC model (as described
in the Model section of this article). This total load volume
includes the preload volume used on the ﬁrst column in PCC
operation as described in the PCC Run Methods section, thus
mimicking the ﬁrst column in the ﬁrst cycle of PCC operation.
The steps performed, the ﬂow rates and volumes for each feed
material are shown in Table 5.
Periodic counter-current chromatography
Octave™ 10 BioSMB Setup. 4 Column PCC (4C-PCC) was
performed on a Semba Octave™ 10 BioSMB (Semba Biosci-
ences, Madison, WI, USA) with ﬁve pumps attached to the
four inlet ports. The inlet ports feed to the valve block with
four HiTrap MabSelect SuRe™ 1 mL columns, with a bed
height of 2.5 cm, attached (GE). The valve block is controlled
by Semba™ Pro software and allows control of the inlets and
outlets of each column, including running columns in series.
A schematic is shown in Figure 3.
The buffers used for each inlet are shown in Table 4. The
Elution outlet was fed directly to a Semba Octave™ 4XE
UV–VIS Detector (Semba Biosciences) ﬁtted with a prepara-
tive ﬂow cell (0.3 mm). Fractionation details are provided in
Single Cycle PCC runs and 100 Cycle Experiments sections,
of the Materials and Methods, for single cycle and 100 cycle
PCC runs, respectively.
Throughout the 4C-PCC, each column is one of seven posi-
tions with its own combination of inlets and outlets (see
Table 6). The feed and ﬂowthrough steps feature two columns
in series, with the outlet of the feed column used as the inlet
Table 4. Process Steps, Buffers, Flow Rates, and Volumes for the Development of Single Column Breakthrough Curves
Step Buffer/Sample Flow Rate (mL/min) Volume (mL)
Equilibration Equilibration buffer 1 10
Feed FT-AEX or depth ﬁlter clariﬁed feed Variable Variable
Post-load wash Equilibration buffer 1 10
Elution Elution buffer 1 8
Acid strip 500 mM acetic acid 0.5 2
Equilibration Equilibration buffer 1 10
Sanitisation 100 mM NaOH 0.3 4.5
Equilibration Equilibration buffer 1 10
Table 5. Flow Rates and Volumes Used for Batch Separations with FT-AEX and Depth Filter Clariﬁed Feed Materials to Mimic Conditions in PCC
Operation
Steps
FT-AEX Clariﬁed Feed Depth Filter Clariﬁed Feed
Flow Rate (mL/min) Volume (mL) Flow Rate (mL/min) Volume (mL)
Equilibration 0.5 10 0.5 10
Feed 1.0 13.5 0.5 20
Post-load wash 0.5 5 0.5 5
Elution 0.5 5 0.5 8
Acid strip N/A N/A 0.5 2
Equilibration 0.5 10 0.5 10
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for the ﬂowthrough column. The wash/strip/equilibration out-
let contains the post-load wash, acid strip, or equilibration
steps combined into a single outlet.
PCC Run Methods. Each of the two feed materials (depth
ﬁlter and FT-AEX clariﬁed material) were run with modiﬁed
methods, however, the base of the method contains the same
three stages:
1. Preload: Initial loading of the feed and ﬂowthrough col-
umns with a small amount of feed.
2. Steady-state cycles: The main loop, repeating for the num-
ber of cycles being run.
3. Post run: A ﬁnal repeat of the steady-state cycle without
the feed and ﬂowthrough positions to elute any remaining
antibody from the columns.
The preload section features just the ﬁrst two columns in
series (feed and ﬂowthrough) with the feed material being
pumped for a set time. The preload time was calculated from
the unbound area of the breakthrough curve as described in
Model section of this article. This section was used to reduce
the time required to reach steady state in continuous operation.
The ﬂow rate used was dependent on the feed material and set
to the value used in the steady-state cycles to ensure a consis-
tent residence time between loading and preloading (0.5 mL/
min for depth ﬁlter clariﬁed feed material and 1 mL/min for
FT-AEX clariﬁed feed material). The preload times were set
to 5 min (2.5 mL) for depth ﬁlter clariﬁed feed material and
3 min (3 mL) for FT-AEX clariﬁed feed material.
For the steady-state cycles, all pump ﬂow rates were run at
0.5 mL/min with the exception of the feed pump (P1) which
was run at 1 mL/min for the FT AEX clariﬁed feed and
0.5 mL/min for the depth ﬁlter clariﬁed material. For the FT-
AEX method, the acid strip position was not used. Each
steady-state cycle was split into four switches (when the feed
switches to the next column). Each of these was split into four
steps; changing the post-load wash, elution, acid strip, or
equilibration positions of the two non-loading columns. The
steady-state cycle steps for each column for the depth ﬁlter
and FT-AEX clariﬁed feed materials are shown in Appendix
Tables A1 and A2, respectively.
The post run cycle is simply a single steady-state cycle with
the feed pump ﬂow rate set to 0 and the “Feed” and “Flow-
through” positions switched to “Rest.” This allows for any
antibody bound to the columns to be eluted and all of the col-
umns to be equilibrated.
Single Cycle PCC Runs. Single cycle experiments were per-
formed with the preload step, a single steady-state cycle and
the post run cycle. Elution fractions were manually collected
from the elution outlet with every switch of the elution column
position. Neutralization buffer was added to each elution frac-
tionation tube: 2 mL for the depth ﬁlter clariﬁed runs and
1 mL for the FT-AEX clariﬁed runs. Flowthrough fractions
were manually collected for the preload step and with every
column switch. Wash/Strip/Equilibration fractions were col-
lected with every column switch.
100 Cycle Experiments. 100 cycle experiments were per-
formed with the preload step, 100 steady-state cycles, and the
post run cycle. Elution fractions were collected from the elu-
tion outlet with every switch of the elution column position.
Neutralization buffer was added to each elution fractionation
tube: 2 mL for the depth ﬁlter clariﬁed run and 1 mL for FT-
AEX clariﬁed run. Flowthrough and Wash/Strip/Elution frac-
tions were collected every 12th cycle (cycles 1, 13, 25, 37,
49, 61, 73, 85, and 97) and the 100th cycle. Intermediate
cycles were pooled. An additional ﬂowthrough fraction was
collected for the preload step.
Analytics
Protein G—Antibody Quantiﬁcation. Antibody quantiﬁca-
tion was performed using a HiTrap Protein G 1 mL column
(GE) attached to an Agilent™ 1200 HPLC system (Agilent,
Santa Clara, CA, USA) with 100 μL injection volume. A
10 min step gradient method was performed with a ﬂow rate
of 2 mL/min throughout. Sodium phosphate (20 mM pH 7.0)
was used as the equilibration buffer with a step gradient to
glycine-HCl (20 mM pH 2.8) after 3 min for elution. The col-
umn was re-equilibrated by a step change to sodium phosphate
after 7.5 min. Antibody concentration was calculated from
peak area at 280 nm based on a theoretical antibody extinction
coefﬁcient of 1.462 mL/mg/cm.
qPCR—DNA quantiﬁcation. CHO HCDNA quantiﬁcation
was performed using Cygnus Technologies CHO Host Cell
DNA kits (#D555T) (Cygnus Technologies, Southport, CA,
USA) according to manufacturer instructions. Power™
SYBR™ Green Master Mix (Life Technologies, Paisley,
Figure 3. Schematic showing the Semba Octave 10 setup.
Table 6. Column Inlets and Outlets for Each Position
Position Inlet Outlet
Flowthrough From feed outlet Flowthrough out
Feed Feed in (P1) To ﬂowthrough in
Post-load wash Post-load wash in (P3) Wash/strip/equilibration out
Elution Elution in (P2) Elution out
Acid strip (depth ﬁlter clariﬁed material only) Acid strip in (P5) Wash/strip/equilibration out
Equilibration Equilibration in (P4) Wash/strip/equilibration out
Rest None None
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U.K.) was used to make up the ampliﬁcation reagent as
recommended by Cygnus Technologies.
ELISA—HCP Quantiﬁcation. CHO host cell protein quan-
tiﬁcation was performed using Cygnus Technologies CHO
Host Cell Protein Kits (#F550) (Cygnus Technologies) accord-
ing to manufacturer instructions.
SEC—Aggregate Quantiﬁcation. Aggregate quantiﬁcation
was performed on selected samples using size exclusion chro-
matography on a Tosoh TSKgel UP-SW3000 (30 cm) (Tosoh
Corporation, Tokyo, Japan) with guard column. An Agilent
1260 HPLC (Agilent) was used with a 5 μL injection volume
and UV detection at 280 nm and 320 nm. A 15 min isocratic
method was used at a ﬂow rate of 0.35 mL/min with a mobile
phase containing 100 mM sodium sulphate and 100 mM
sodium phosphate at pH 6.7.
Results and Discussion
Analysis of single column runs to provide parameters for the
PCC model
Figure 4 shows the breakthrough curves generated at different
residence times on single 1 mL HiTrap MabSelect SuRe™ pro-
tein A column with both depth ﬁlter and FT-AEX clariﬁed feed
material. As the residence time decreases, the breakthrough
curve shifts to the left and the sharpness of the breakthrough
curve diminishes as expected and has been recorded and
explained by others in the literature.21 In the context of PCC,
while lower residence time results in higher productivity, it also
has the effect of reducing the usable capacity during PCC opera-
tion. This is because a larger proportion of the product ﬂows
through the column for more of the load volume, thereby result-
ing in greater preloading of the ﬂowthrough column.
There is no signiﬁcant difference in the breakthrough behav-
ior of FT-AEX clariﬁed feed material compared to the depth ﬁl-
ter clariﬁed feed material, particularly at higher residence
times. FT-AEX clariﬁed material has been shown to have sig-
niﬁcantly less DNA than material clariﬁed through a standard
two-stage depth ﬁltration train, and consequently less chroma-
tin.19 Therefore, this result appears to contradict the ﬁndings of
Gagnon et al. who reported that protein A dynamic binding
capacity increased by 20% when chromatin depleted feed mate-
rial was used to feed the protein A column.22 However, given
that Gagnon focuses on batch conditions, and so does not go
further than 10% breakthrough, it may be that, upon overload-
ing the column, chromatin is competed off by the antibody.
Alternatively, the contradictory performance may simply be
due to differences in the feed material. For example, the mate-
rial used in Gagnon’s work was harvested at day 15–30 with
viabilities of 20–50%. The material used in this work was har-
vested at day 14 with a viability of 64% or greater.
A difference was, however, observed between the regenera-
tion steps on columns loaded with FT-AEX clariﬁed material
when compared to those loaded with depth ﬁlter clariﬁed feed
material. Figure 5a shows the elution, acid strip, equilibration,
and sanitisation steps following loading with FT-AEX clariﬁed
material compared to depth ﬁlter clariﬁed material. The FT-
AEX clariﬁed material results in a sharper elution peak, no
acid strip peak, and a smaller sanitisation peak.
As a result of this ﬁnding, the regeneration for the FT-AEX
clariﬁed material was shortened by reducing the elution to
Figure 4. Breakthrough curves generated using depth ﬁlter clar-
iﬁed feed material at a loading residence time of
0.25 min (black squares), 0.5 min (black circles),
1 min (black triangles), 2 min (black upside-down tri-
angles), and 4 min (black diamonds) compared with
breakthrough curves generated with FT-AEX clariﬁed
feed material at a residence time of 0.25 min (white
squares), 0.5 min (white circles), 1 min (white trian-
gles), 2 min (white upside-down triangles), and 4 min
(white diamonds).
Figure 5. Figures showing regeneration steps performed during batch experiments to deﬁne conditions for the PCC runs. Graph
(a) shows elution, acid strip, equilibration and sanitisation steps following a load of 40 mL with depth ﬁlter clariﬁed feed mate-
rial (dashed line) and FT-AEX clariﬁed material (solid line). Graph (b) shows the modiﬁed regenerations steps following a
20 mL load for depth ﬁlter clariﬁed material (dashed line) and a 13.5 mL load of FT-AEX clariﬁed material (solid line). The
non-required acid strip and post acid strip equilibration were removed in this FT-AEX clariﬁed feed run.
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5 column volumes and removing the acid strip while maintain-
ing the re-equilibration at 10 column volumes. As can be seen
from Figure 5b, this shortened regeneration does not result in
any signiﬁcant change in the sanitisation peak for the FT-AEX
clariﬁed material. As a result, these modiﬁed conditions were
taken forward into the model and subsequent PCC runs.
PCC model predictions
The experimental data from the breakthrough curves and opti-
mized regeneration were applied to the model. Figure 6 shows
the predicted productivities for a 3 and 4 column system using
depth ﬁlter clariﬁed material (a) and (c), respectively, and
using FT-AEX clariﬁed material (b) and (d), respectively. The
model predicts that for both 3 and 4 column systems the FT-
AEX clariﬁed material allows for better productivities than depth
ﬁlter clariﬁed material. This is due to the ability to shorten the
regeneration which provides better matching between load and
regeneration steps for the three column system, and the use of
lower residence times on a 4 column system.
The combination of FT-AEX clariﬁed feed material and a
3 column system was shown to achieve productivity gains of
28% over depth ﬁlter clariﬁed feed material with a 4 column
system. The reduction in the number of columns and increased
productivity demonstrates chromatographic clariﬁcation as a
useful tool to aid simpliﬁcation of PCC.
A 4 column system at 1 min residence time with FT-AEX
clariﬁed material gave rise to the highest predicted productiv-
ity. It is of note that further optimization is possible as the
load was shorter than the regeneration by 4.5 min. By asses-
sing performance at residence times of between 1 and 2 min,
it would have been possible to further increase the
productivity. However, the productivity gains predicted were
thought sufﬁcient as proof of concept.
Experimental validation of PCC model productivity
predictions
The productivity predictions of the model were validated
experimentally. Figure 7 compares the single and 100 cycle pro-
ductivity predictions, for both FT-AEX clariﬁed feed material
and depth ﬁlter clariﬁed material, to the experimental results.
The single cycle runs were performed in duplicate. There was
no signiﬁcant difference between the experimental productiv-
ities obtained. The 100 cycle runs were completed as a single
replicate. Eluate titer measurements were taken for all four col-
umns every 12 cycles. Excellent reproducibility was observed
in eluate titers between the columns and across the cycles with
an average mass of antibody eluted of 44.41 mg and a standard
error of 0.34 mg for the depth ﬁlter clariﬁed feed material and
an average mass of antibody eluted of 32.98 mg with a standard
error of 0.11 mg for the FT-AEX clariﬁed material.
The largest difference between predicted productivity and
that achieved experimentally occurred for the single cycle
PCC run with depth ﬁlter clariﬁed feed material. This differ-
ence was 12.2%. This demonstrates good agreement between
the model and experimental results and provides a similar
level of agreement to the model proposed by Baur et al. The
largest difference between the predicted and modeled produc-
tivity was 8.9% in their work.10
PCC performance with different feeds
The PCC performance in terms of yield, HCP concentra-
tion, HCDNA concentration, and aggregates was measured at
Figure 6. Predicted productivities using the mathematical model for a 3 column system with depth ﬁlter clariﬁed feed material (a), 3 col-
umn system using FT-AEX clariﬁed feed material (b), a 4 column system with depth ﬁlter clariﬁed feed material (c) and a 4 col-
umn system with FT-AEX clariﬁed feed material (d). These plots are based on the ﬁve residence times and use linear
interpolation for intermediate values.
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various points within the 100 cycle experiments for both the
FT-AEX and depth ﬁlter clariﬁed material.
Yield. Figure 8 shows the average yield across all four col-
umns versus cycle number. The yield is lower for the ﬁrst
cycle as this includes the initial preloading step. This preload
is essentially passed from column to column during the run
and is ﬁnally recovered in the post run regeneration steps. This
is supported by the overall yield, in Table 7, which is approxi-
mately the same as the yield achieved from cycle 2 onwards.
The 100 cycle runs with depth ﬁlter clariﬁed feed material
do exhibit a lower yield than that of the FT-AEX clariﬁed feed
material. This is due to the difference in operating conditions.
In particular, the fact that more material was loaded on to the
column for the PCC runs with depth ﬁlter clariﬁed feed mate-
rial. This would have resulted in the columns being more satu-
rated causing the last column volume of feed material, before
switching to post-load wash, to contain more product. As this
material would have been ﬂushed to waste, this would cause
the reduction in yield. This would also explain the lower yield
compared to the batch short load (see Table 7). This lost mate-
rial could be retained by washing on to next column in the
loading zone, an approach that has been used by others.23
The lower yields displayed in Table 7 for the long load
batch experiments, where the columns were loaded up to the
same level of breakthrough as the PCC runs, are explained by
the fact that there was no second column to bind unbound
mAb in the ﬂowthrough. As the FT-AEX batch protein A run
was loaded with less product, less product is lost.
Host Cell Protein. As observed in Figure 8, the HCP con-
centration in the FT-AEX clariﬁed protein A PCC eluates is at
least one order of magnitude lower than that of the depth ﬁlter
clariﬁed protein A PCC eluates. In addition, the trends
between the two challenges are different. The HCP concentra-
tion in FT-AEX material remains constant or increases slightly
whereas that of the depth ﬁlter material shows a downward
trend.
It is hypothesized that this downward trend occurs as a
result of fouling on the protein A column as there is no saniti-
sation step during the 100 cycle PCC experiment. Coelution
of HCPs from protein A resin, as a result of binding to the
resin rather than the product, has been shown to be minimal
by Tarrant et al.24 but this work did not look at what remained
on the matrix following elution. In contrast, Gagnon
et al. looked at binding of chromatin to the protein A ligand
and found that chromatin remained bound following elution
and was responsible for leaching HCP contaminants into the
eluate.22 As the cycles progress, the additional fouling of the
resin with chromatin may reduce the leaching of HCP’s from
the column thereby reducing their levels in the eluate. Given
that the FT-AEX feed material contains much less DNA, and
consequently much less chromatin, this would explain why
HCP levels remain much more constant.
When comparing the HCP levels in Table 7, the batch long
and short load show similar levels of HCP in the eluate while
the PCC runs appear to have signiﬁcantly more HCP. How-
ever, the ratio of HCP concentrations in the PCC eluates using
depth ﬁlter and FT-AEX clariﬁed material is the same as the
ratio of HCP in the eluates of the long load batch experiments.
In both cases, the FT-AEX clariﬁed material gives rise to a
HCP concentration approximately 11 times lower than that of
the depth ﬁlter clariﬁed material. Therefore, both batch and
PCC experiments support the previous ﬁndings of Castro-
Figure 7. Productivities achieved experimentally versus those
predicted by the model. The solid black bars show the
predicted productivities for FT-AEX clariﬁed mate-
rial and the dark hashed bars show the experimen-
tally achieved productivities for FT-AEX clariﬁed
material. The white bars show the predicted produc-
tivities for depth ﬁlter clariﬁed material and the light
hashed bars show the experimentally achieved pro-
ductivities for depth ﬁlter clariﬁed material. The (▽)
show replicates of the single cycle runs.
Figure 8. Graph showing yield, Host Cell Protein and Host Cell
DNA concentration of the eluates versus cycle number
for the 100 cycle PCC experiments. The yield (white
squares) Host Cell Protein concentration (black
squares) and Host Cell DNA concentration (black tri-
angles) in the eluates from the PCC experiment using
depth ﬁlter clariﬁed material as the feed are compared
to the yield (white circles) and Host Cell Protein con-
centration (black circles) in the eluates from the PCC
experiment using FT-AEX clariﬁed material as
the feed.
Biotechnol. Prog., 2018 9
Forero et al.19 It is thought that the concentration of HCP is
higher in the PCC eluates as the whole eluate was collected,
whereas just the peak was collected for the batch experiments.
If HCPs are leached during the elution then collecting just the
peak will get rid of HCPs eluted outside of this peak, whereas
collecting the whole eluate would not.
Host Cell DNA. Figure 8 shows the HCDNA concentration
versus cycle number for the PCC eluates obtained using the
depth ﬁlter clariﬁed material. The DNA concentration versus
cycle number for PCC eluates obtained using FT-AEX clari-
ﬁed material are not plotted as these were below the limit of
detection of the assay.
As with the HCP concentration, a downward trend in DNA
concentration in the eluates for depth ﬁlter clariﬁed feed mate-
rial is observed with cycle number. By contrast to the reduc-
tion in HCP concentration, the reduction in DNA
concentration does not level off. This suggests that DNA,
probably in the form of chromatin, continues to bind to the
column in increasing quantities as the cycles progress and the
column becomes more fouled. This supports the hypothesis of
the importance of DNA, and chromatin, in particular, with
respect to column fouling.
Overall the level of DNA, in the PCC eluates, is 4.40 log
lower for the FT-AEX clariﬁed feed material than that from
the depth ﬁlter clariﬁed feed material. A similar difference is
seen in the long load batch results with the DNA in the protein
A eluates from the FT-AEX clariﬁed material being 4.35 log
lower than for the depth ﬁlter clariﬁed material. Therefore,
both batch and PCC experiments support the previous ﬁndings
of Castro-Forero et al. who found protein A eluates using FT-
AEX clariﬁed material contained 3.5 log less HCDNA than
protein A eluates from depth ﬁlter clariﬁed material.19
Aggregates and Low Molecular Weight Impurities. Table 7
shows the average mAb monomer content, across cycle 2 and
100, in the protein A PCC eluates for depth ﬁlter clariﬁed feed
material and FT-AEX clariﬁed feed material. The long load
batch run protein A eluate monomer content, for depth ﬁlter
clariﬁed feed material, is also shown. While the amount of
product related impurities does appear slightly lower for the
PCC eluates from the run using FT-AEX clariﬁed feed
material, the difference is small. There are also slightly higher
levels of product related impurities in the PCC run with depth
ﬁlter clariﬁed feed material, when compared to the long load
batch run with the same feed material, and small decrease
(from 96.2% to 95.7%) in the monomer content between cycle
2 and 100 for the PCC runs with this material. In contrast, the
levels of monomer in the PCC eluates from the run using FT-
AEX clariﬁed feed material where more consistent (98.3%
and 98.4%, respectively). The small difference in the levels of
product related impurities may be due to the fouling described
in Host Cell Protein section of the Results and Discussion,
which is consistent with the work of Lintern et al.25 who
found a progressive reduction in the number of mAb and pro-
tein A fragments which were associated with the resin as the
cycle number increased. However, due to the low magnitude
of the differences and number of measurements taken, further
investigation would be needed to draw ﬁrm conclusions for
these differences.
Productivity and Capacity Utilization. Table 7 also shows
the productivities achieved in batch and PCC mode for the dif-
ferent feed materials. The batch run with normal loading gave
rise to the lowest productivity. As expected, the longer loading
batch runs for both depth ﬁlter and FT-AEX clariﬁed feed
materials resulted in a signiﬁcant increase in productivity due
to the additional loading, shorter residence time, and opti-
mized regeneration conditions. However, as there was no col-
umn to catch product ﬂowing through during overloading, the
yield was adversely affected as discussed in the Yield
section of the Results and Discussion.
As expected, the PCC runs resulted in the highest produc-
tivities. The PCC run with FT-AEX clariﬁed feed material
resulted in the highest productivity which was 164% greater
than batch and 49% better than the PCC runs with depth
ﬁlter clariﬁed material. This demonstrates that chromato-
graphic clariﬁcation is a useful tool for enhancing the
performance of protein A PCC for mAb capture. The
increase in productivity seen between the long load batch
runs and PCC runs is due to the fact that the regeneration
steps happen in parallel with loading on other columns, for
the PCC runs, reducing the impact of regeneration time on
productivity.
Table 7. Key Performance Characteristics of the 100 Cycle PCC Experiments with Depth Filter and FT-AEX Clariﬁed Feed Material Compared to
a Batch Run with a Normal Load, and Long Load Batch Runs which Were Loaded to the Same Degree as Their Respective PCC Runs. For Data
Associated with the PCC Runs, the Standard Deviation is Presented in Brackets Below the Value. The Number in Square Brackets Underneath the
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The relative capacity utilization was highest for the PCC
runs using depth ﬁlter clariﬁed material. It was 83% higher
than that of the normal load batch run and 35% higher than
the FT-AEX PCC run. This is because the load volume was
greater and the residence time was longer. Capacity utiliza-
tion with the FT-AEX clariﬁed feed could have been further
improved by looking at residence times between 1 and
2 min as described in PCC Model Predictions section of this
article.
It has been argued that maximizing capacity utilization is
important for expensive resins.10 This is only true if the num-
ber of cycles that can be performed on the resin is constant,
which may not always be the case. Pollock et al. showed that
utilizing 100% of a resin’s capacity can accelerate capacity
loss.15 However, Mahajan et al. did not observe the same effect
when a more alkali stable media was used up to 70% break-
through.26 The difference between the ﬁndings of these two
studies could be due to the higher loading in the ﬁrst study and
or the increased alkaline resistance in the second. In either case,
the reduced fouling observed for the FT-AEX PCC runs could
allow less frequent sanitisation, and the reduced loading could
allow the resin to be used for more cycles, both of which could
reduce the impact of the lower capacity utilization.
Post Use Pressure Drop and Column Discoloration. The
fouling hypothesis discussed in the Host Cell Protein section,
of the Results and Discussion, is supported by visual inspec-
tion of the protein A columns following 100 PCC cycles
(Figure 9) which shows that the column exposed to depth ﬁlter
clariﬁed feed material is more discolored than the one fed with
FT-AEX clariﬁed material.
The pressure drop across the columns following the
100 cycle PCC runs was also measured on an ÄKTA™
Avant using equilibration buffer. The pressure drop across a
fresh column using the same buffer was measured and sub-
tracted from the post PCC pressure. The results, in Table 7,
show a signiﬁcantly higher pressure drop for those columns
on which the PCC was performed using depth ﬁlter clariﬁed
feed material, again supporting the conclusion of greater foul-
ing on PCC columns loaded with depth ﬁlter clariﬁed feed
material.
Conclusions
The research presented in this article has shown that chro-
matographic clariﬁcation is able to improve the product purity
achieved during protein A PCC by reducing the level of HCP
by 11-fold and HCDNA concentration by 4.4 LRV when
compared to PPC eluates from depth ﬁlter clariﬁed material.
This was similar to purity improvements demonstrated in
batch processes.19 The levels of product related impurities
were comparable between the second and last cycles of the
FT-AEX PCC runs, and comparable to the batch long load
runs with depth ﬁlter clariﬁed feed material, indicating that the
performance of the PCC in terms of product related impurities
remained consistent over the 100 cycles tested.
In addition, chromatographic clariﬁcation using the
Emphaze™ AEX Hybrid Puriﬁer was able to enhance the pro-
ductivity of the protein A PCC by 49% compared to standard
depth ﬁlter clariﬁed material. This was due to the shorter
regeneration, which allowed for shorter loading residence
times to be used while maintaining the balance between load-
ing and regeneration. The use of shorter loading residence
time is the main driver for increased productivity. FT-AEX
clariﬁed material also provides the option to reduce the num-
ber of columns from 4 to 3 with productivity gains of 28%, as
predicted by the model presented herein. In addition, reduced
fouling seen on the FT-AEX PCC runs could provide the
option for less frequent sanitisation, allowing more cycles to
be completed per column with less capacity loss, and helping
to drive down the cost of the protein A step.
Based on these results, it has been demonstrated that chro-
matographic clariﬁcation is a useful tool for enhancing the per-
formance of PCC both in terms of purity and cost. By replacing
the polishing grade depth ﬁlter, chromatographic clariﬁcation
using the Emphaze™ AEX Hybrid Puriﬁer can be easily incor-
porated into a batch or continuous process, in a scalable fashion,
without adding additional separate unit operations.
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Table A1 Step Times and Column Positions for the Depth Filter Clariﬁed Feed Material
Switch. Step Step Time Column 1 Column 2 Column 3 Column 4
1.1 10 Feed Flowthrough Equilibration PL wash
1.2 10 Feed Flowthrough Equilibration Elution
1.3 6 Feed Flowthrough Rest Elution
1.4 4 Feed Flowthrough Rest Acid Strip
2.1 10 PL wash Feed Flowthrough Equilibration
2.2 10 Elution Feed Flowthrough Equilibration
2.3 6 Elution Feed Flowthrough Rest
2.4 4 Acid Strip Feed Flowthrough Rest
3.1 10 Equilibration PL wash Feed Flowthrough
3.2 10 Equilibration Elution Feed Flowthrough
3.3 6 Rest Elution Feed Flowthrough
3.4 4 Rest Acid Strip Feed Flowthrough
4.1 10 Flowthrough Equilibration PL wash Feed
4.2 10 Flowthrough Equilibration Elution Feed
4.3 6 Flowthrough Rest Elution Feed
4.4 4 Flowthrough Rest Acid Strip Feed
Table A2 Step Times and Column Positions for the FT-AEX Clariﬁed Feed Material
Step Step Time Column 1 Column 2 Column 3 Column 4
1.1 5 Feed Flowthrough Elution PL wash
1.2 5 Feed Flowthrough Equilibration PL wash
1.3 0.5 Feed Flowthrough Equilibration Elution
1.4 4.5 Rest Rest Equilibration Elution
2.1 5 PL wash Feed Flowthrough Elution
2.2 5 PL wash Feed Flowthrough Equilibration
2.3 0.5 Elution Feed Flowthrough Equilibration
2.4 4.5 Elution Rest Rest Equilibration
3.1 5 Elution PL wash Feed Flowthrough
3.2 5 Equilibration PL wash Feed Flowthrough
3.3 0.5 Equilibration Elution Feed Flowthrough
3.4 4.5 Equilibration Elution Rest Rest
4.1 5 Flowthrough Elution PL wash Feed
4.2 5 Flowthrough Equilibration PL wash Feed
4.3 0.5 Flowthrough Equilibration Elution Feed
4.4 4.5 Rest Equilibration Elution Rest
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